1 Du L,Wang Y,Sun X,et al.Thyroid cancer:trends in incidence,mortality and clinical-pathological patterns in Zhejiang Province,Southeast China[J].BMC Cancer,2018,18(1):291. 2 Lim H,Devesa SS,Sosa JA,et al.Trends in thyroid cancer incidence and mortality in the United States,1974—2013[J].JAMA,2017,317:1338-1348. 3 Wu Y,Wang L,Wang X,et al.RNA sequencing analysis reveals the competing endogenous RNAs interplay in resected hepatocellular carcinoma patients who received interferon-alpha therapy[J].Cancer Cell Int,2021,21(1):464. 4 Hu Y,Zhang X,Wang O,et al.The genomic profile of parathyroid carcinoma based on whole-genome sequencing[J].Int J Cancer,2020,147(9):2446-2457. 5 Jin Y J,Aycheh HM,Han S,et al.Differential alternative splicing between hepatocellular carcinoma with normal and elevated serum alpha-fetoprotein[J].BMC Med Genomics,2020,13(11):194. 6 Hyuna S,Jacques F,Rebecca L,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71(3):209-249. 7 Abdullah MI,Junit SM,Ng KL,et al.papillary thyroid cancer:genetic alterations and molecular biomarker investigations[J].Int J Med Sci,2019,16(3):450-460. 8 Nan BY,Xiong GF,Zhao ZR,et al.Comprehensive identification of potential crucial genes and miRNA-mRNA regulatory networks in papillary thyroid cancer[J].Biomed Res Int,2021,2021:6752141. 9 Singh Ospina N,Iñiguez-Ariza NM,Castro MR.Thyroid nodules:diagnostic evaluation based on thyroid cancer risk assessment[J].BMJ,2020,368:l6670. 10 Sheetz JB,Lemmon MA.Looking lively:emerging principles of pseudokinase signaling[J].Trends Biochem Sci,2022,47(10):875-891. 11 Riegel K,Vijayarangakannan P,Kechagioglou P,et al.Recent advances in targeting protein kinases and pseudokinases in cancer biology[J].Front Cell Dev Biol,2022,(10):942500. 12 Nalbant D,Youn H,Nalbant SI,et al.FAM20:an evolutionarily conserved family of secreted proteins expressed in hematopoietic cells[J].BMC Genomics,2005,6:11. 13 Martha L Slattery,Lila E Mullany,Roger K Wolff,et al.The p53-signaling pathway and colorectal cancer:Interactions between downstream p53 target genes and miRNAs-PubMed.Genomics,2019,111(4):762-771. 14 贺伟,母齐鸣,王 刚,等.TACC3和p53蛋白在原发性肝癌组织中的表达及其临床意义[J].实用肿瘤学杂志.2018,32(5):420-425. 15 徐娟,贲海祥,丁琳琳,等.基于潜在类别分析的不同CD73多发性骨髓瘤患者预后复发的影响因素分布特征研究[J].实用肿瘤学杂志,2022,36(4):332-338. 16 Hernández Borrero LJ,El-Deiry WS.Tumor suppressor p53:Biology,signaling pathways,and therapeutic targeting[J].Biochim Biophys Acta Rev Cancer,2021,1876(1):188556. |